Showing results (251-260 of 867) with videos related to
Sort By:
Pageof 87
Journal of the American College of Cardiology|December 17, 2016
Prosthetic Heart Valve ThrombosisGeorge D Dangas, Jeffrey I Weitz, Gennaro Giustino, et al.The Journal of Biological Chemistry|October 19, 2006
HD1, a thrombin-directed aptamer, binds exosite 1 on prothrombin with high affinity and inhibits its activation by prothrombinaseColin A Kretz, Alan R Stafford, James C Fredenburgh, et al.The Journal of Biological Chemistry|July 2, 2003
Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharideEricka M Wiebe, Alan R Stafford, James C Fredenburgh, et al.Blood|August 1, 2002
Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotypeSepideh Akhavan, Raimondo De Cristofaro, Flora Peyvandi, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2011
Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in IranPeyman Eshghi, Nader Cohan, Manigeh Lak, et al.Journal of Clinical Medicine|February 25, 2023
Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet NeedsGiancarlo Castaman, Flora Peyvandi, Raimondo De Cristofaro, et al.Thrombosis Research|August 8, 2013
Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal statusFranca Franchi, Eugenia Biguzzi, Ida Martinelli, et al.Transfusion|August 6, 2022
Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trialsClaudia Djambas Khayat, Sunil Lohade, Omid Reza Zekavat, et al.Seminars in Thrombosis and Hemostasis|June 19, 2018
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand SyndromeFrancesca Stufano, Marco Boscarino, Paolo Bucciarelli, et al.Haematologica|September 28, 2019
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpuraSilvia Riva, Ilaria Mancini, Alberto Maino, et al.Pageof 87